Pipeline
Our primary focus is in the colorectal area. TAVT-119 is a late-stage product in development for anal fissure, a common and very painful condition.
We are also evaluating commercial opportunities for TAVT-45 in prostate cancer, which recently completed Phase 3.
Program
Indication
- Pre-ind Pre-ind
- Ph 1 Ph 1
- Ph 2 Ph 2
- Ph 3 Ph 3
- Approval Approval